2017
DOI: 10.1158/2159-8290.cd-17-0292
|View full text |Cite
|
Sign up to set email alerts
|

Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade

Abstract: Clear cell renal cell carcinoma (ccRCC) is characterized by BAP1 and PBRM1 mutation, which are associated with tumors of different grade and prognosis. However, whether BAP1 and PBRM1 loss causes ccRCC and determines tumor grade is unclear. We conditionally targeted Bap1 and Pbrm1 (with Vhl) in the mouse using several Cre drivers. Sglt2 and Villin proximal convoluted tubule drivers failed to cause tumorigenesis, challenging the conventional notion of ccRCC origins. In contrast, targeting with Pax8, a developme… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

16
134
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 141 publications
(150 citation statements)
references
References 65 publications
16
134
0
Order By: Relevance
“…Transcriptional profiling of human ccRCC indicate that PBRM1 mutant tumors have a hypoxic transcriptional signature (Sato et al, 2013), which is in agreement with recent reports that PBRM1 mutation amplifies the hypoxia inducible factor (HIF) transcriptional program signature induced upon von Hippel-Lindau (VHL) deletion in cell culture (Gao et al, 2017) and in a mouse model of renal cancer (Nargund et al, 2017). Recent work with kidney specific (KSP and PAX8) Cre mouse models indicate that VHL knockout or PBRM1 knockout alone is not sufficient for cancer formation but that both are required for kidney tumor formation in mice (Espana-Agusti et al, 2017;Gu et al, 2017;Nargund et al, 2017).…”
supporting
confidence: 86%
“…Transcriptional profiling of human ccRCC indicate that PBRM1 mutant tumors have a hypoxic transcriptional signature (Sato et al, 2013), which is in agreement with recent reports that PBRM1 mutation amplifies the hypoxia inducible factor (HIF) transcriptional program signature induced upon von Hippel-Lindau (VHL) deletion in cell culture (Gao et al, 2017) and in a mouse model of renal cancer (Nargund et al, 2017). Recent work with kidney specific (KSP and PAX8) Cre mouse models indicate that VHL knockout or PBRM1 knockout alone is not sufficient for cancer formation but that both are required for kidney tumor formation in mice (Espana-Agusti et al, 2017;Gu et al, 2017;Nargund et al, 2017).…”
supporting
confidence: 86%
“…Pax8 -Cre was used to delete Vhl and Bap1 or Pbrm1 within the proximal and distal renal tubules, loops of Henle, collecting ducts, and parietal cells of the Bowman capsule [52]. Sglt2 - and Villin -Cre were also used for more specific deletion within proximal tubule epithelial cells.…”
Section: Genetic Mouse Models Of Renal Cell Carcinomamentioning
confidence: 99%
“…PBRM1deficient cancer cells exhibit a weakened HIF transcriptional signature (Gao et al, 2017). In mice, kidney-specific deletion of either Vhl or Pbrm1 does not lead to ccRCC, but their combined loss does (Gu et al, 2017;Nargund et al, 2017). Thus, PBRM1 restrains HIF's tumor-promoting activity.…”
Section: Introductionmentioning
confidence: 99%